Human B lymphoma cell line producing B cell growth factor
- PMID: 2982918
- PMCID: PMC423567
- DOI: 10.1172/JCI111754
Human B lymphoma cell line producing B cell growth factor
Abstract
Namalva, a human B cell lymphoma line, produced a factor with a molecular weight of approximately 60,000 which enhanced the proliferation of normal activated human B lymphocytes. The factor also enhanced the proliferation of certain B cell lines. It can be distinguished physiologically and biochemically from other lymphokines known to enhance B cell proliferation, namely, interleukin (IL) 1, IL 2, and interferon. The production of B cell growth factor by B cell tumor lines may contribute to their ability to grow autonomously and may reflect an important component of the neoplastic potential of the cell. B cell growth factor produced by tumors may also affect normal cells in vivo.
Similar articles
-
Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line.J Immunol. 1986 Mar 15;136(6):2158-63. J Immunol. 1986. PMID: 3485143
-
Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).J Immunol. 1985 Mar;134(3):1728-33. J Immunol. 1985. PMID: 2981920
-
Production of B cell growth factor by normal human B cells.J Immunol. 1986 Jun 15;136(12):4542-7. J Immunol. 1986. PMID: 3519772
-
Inducible lymphokines of T cell tumors.Crit Rev Immunol. 1986;6(1):71-103. Crit Rev Immunol. 1986. PMID: 3522104 Review.
-
Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis.Med Oncol Tumor Pharmacother. 1986;3(3-4):269-73. doi: 10.1007/BF02935004. Med Oncol Tumor Pharmacother. 1986. PMID: 3027466 Review.
Cited by
-
Human T cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin 2 by differentiation in the absence of enhanced proliferation.J Exp Med. 1985 Jul 1;162(1):393-8. doi: 10.1084/jem.162.1.393. J Exp Med. 1985. PMID: 2989412 Free PMC article.
-
Early Changes of Serum Interleukin 14α Levels Predicts the Response to Anti-PD-1 Therapy in Cancer.Clin Med Insights Oncol. 2023 Apr 19;17:11795549231163369. doi: 10.1177/11795549231163369. eCollection 2023. Clin Med Insights Oncol. 2023. PMID: 37101524 Free PMC article.
-
Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies.J Clin Invest. 1992 Sep;90(3):945-52. doi: 10.1172/JCI115971. J Clin Invest. 1992. PMID: 1326002 Free PMC article.
-
Identification of a cDNA for a human high-molecular-weight B-cell growth factor.Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6330-4. doi: 10.1073/pnas.90.13.6330. Proc Natl Acad Sci U S A. 1993. PMID: 8327514 Free PMC article.
-
Association between B Cell Growth Factors and Primary Sjögren's Syndrome-Related Autoantibodies in Patients with Non-Hodgkin's Lymphoma.J Immunol Res. 2019 Jan 13;2019:7627384. doi: 10.1155/2019/7627384. eCollection 2019. J Immunol Res. 2019. PMID: 30766889 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources